Monoclonal antibodies (mAbs) Biosimilars Market Report

Global and China Monoclonal antibodies (mAbs) Biosimilars Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 14, 2022
  • PAGES：212
  • REPORT CODE：GMM1465581
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of quality, efficacy and safety to an innovative reference medicinal product.According to the report, one driver that will lead to the growth of this market is the rise in number of patent expiries.

    This report elaborates on the current development of the Monoclonal antibodies (mAbs) Biosimilars industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • 3SBio

    • AET Biotech

    • Dr Reddy's Laboratories

    • Hospira

    • Allergan

    • Amega Biotech

    • Accord Healthcare

    • Others

    • Biocon

    • Celltrion

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Erythropoietin (EPO)

    • Human Growth Hormone (HGH)

    • Granulocyte- Colony Stimulating Factor (G-CSF)

    • Monoclonal Antibody (mAb)

    • Insulin

    • Interferon (IFN)

    • Celltrion

    Application:

    • Anti-Cancer

    • Anti-Inflammatory/Autoimmune

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Monoclonal antibodies (mAbs) Biosimilars Industry Overview

      • 1.1.1 Monoclonal antibodies (mAbs) Biosimilars Market Scope and Market Segments

      • 1.1.2 Monoclonal antibodies (mAbs) Biosimilars Industry Characteristics

      • 1.1.3 Global and China Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Monoclonal antibodies (mAbs) Biosimilars Production Value and Growth Rate (2017-2028)

    • 1.2 Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Erythropoietin (EPO)

      • 1.2.2 Human Growth Hormone (HGH)

      • 1.2.3 Granulocyte- Colony Stimulating Factor (G-CSF)

      • 1.2.4 Monoclonal Antibody (mAb)

      • 1.2.5 Insulin

      • 1.2.6 Interferon (IFN)

      • 1.2.7 Celltrion

    • 1.3 Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Anti-Cancer

      • 1.3.2 Anti-Inflammatory/Autoimmune

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Monoclonal antibodies (mAbs) Biosimilars Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Monoclonal antibodies (mAbs) Biosimilars Industry Porter's Five Forces Model Analysis

      • 2.2.3 Monoclonal antibodies (mAbs) Biosimilars Industry PEST Analysis

    • 2.3 Monoclonal antibodies (mAbs) Biosimilars Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Monoclonal antibodies (mAbs) Biosimilars Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Monoclonal antibodies (mAbs) Biosimilars Industry

    Chapter 3 Global and China Monoclonal antibodies (mAbs) Biosimilars Market, by Manufacturer

    • 3.1 Global and China Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Monoclonal antibodies (mAbs) Biosimilars Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Monoclonal antibodies (mAbs) Biosimilars Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Monoclonal antibodies (mAbs) Biosimilars Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Monoclonal antibodies (mAbs) Biosimilars Market Top 3 Players

    Chapter 4 Global and China Monoclonal antibodies (mAbs) Biosimilars Market, by Type (2017-2028)

    • 4.1 Monoclonal antibodies (mAbs) Biosimilars Market Trend, by Type

    • 4.2 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Monoclonal antibodies (mAbs) Biosimilars Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Monoclonal antibodies (mAbs) Biosimilars Price Trend, by Type (2017-2028)

    • 4.3 China Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Monoclonal antibodies (mAbs) Biosimilars Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Monoclonal antibodies (mAbs) Biosimilars Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Monoclonal antibodies (mAbs) Biosimilars Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Monoclonal antibodies (mAbs) Biosimilars Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Monoclonal antibodies (mAbs) Biosimilars Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Monoclonal antibodies (mAbs) Biosimilars Market Analysis

    • 7.1 North America Monoclonal antibodies (mAbs) Biosimilars Market, by Type

    • 7.2 North America Monoclonal antibodies (mAbs) Biosimilars Market, by Application

    • 7.3 North America Monoclonal antibodies (mAbs) Biosimilars Market Analysis and Forecast, by Country

      • 7.3.1 United States Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Monoclonal antibodies (mAbs) Biosimilars Market Analysis

    • 8.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market, by Type

    • 8.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market, by Application

    • 8.3 Europe Monoclonal antibodies (mAbs) Biosimilars Market Analysis and Forecast, by Country

      • 8.3.1 Germany Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Monoclonal antibodies (mAbs) Biosimilars Market Analysis

    • 9.1 APAC Monoclonal antibodies (mAbs) Biosimilars Market, by Type

    • 9.2 APAC Monoclonal antibodies (mAbs) Biosimilars Market, by Application

    • 9.3 APAC Monoclonal antibodies (mAbs) Biosimilars Market Analysis and Forecast, by Country

      • 9.3.1 China Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Analysis

    • 10.1 Latin America, Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market, by Type

    • 10.2 Latin America, Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market, by Application

    • 10.3 Latin America, Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Monoclonal antibodies (mAbs) Biosimilars Company Profiles

      • 11.1 3SBio

        • 11.1.1 3SBio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 3SBio Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification

        • 11.1.3 3SBio Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 AET Biotech

        • 11.2.1 AET Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 AET Biotech Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification

        • 11.2.3 AET Biotech Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Dr Reddy's Laboratories

        • 11.3.1 Dr Reddy's Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Dr Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification

        • 11.3.3 Dr Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Hospira

        • 11.4.1 Hospira Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Hospira Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification

        • 11.4.3 Hospira Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Allergan

        • 11.5.1 Allergan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Allergan Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification

        • 11.5.3 Allergan Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Amega Biotech

        • 11.6.1 Amega Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification

        • 11.6.3 Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Accord Healthcare

        • 11.7.1 Accord Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification

        • 11.7.3 Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Others

        • 11.8.1 Others Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Others Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification

        • 11.8.3 Others Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Biocon

        • 11.9.1 Biocon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Biocon Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification

        • 11.9.3 Biocon Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Celltrion

        • 11.10.1 Celltrion Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Celltrion Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification

        • 11.10.3 Celltrion Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Monoclonal antibodies (mAbs) Biosimilars Industry Investment Prospect and Risk Assessment

    • 12.1 Monoclonal antibodies (mAbs) Biosimilars Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Monoclonal antibodies (mAbs) Biosimilars Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure China Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Global Monoclonal antibodies (mAbs) Biosimilars Production Value and Growth Rate (2017-2028)

    • Figure China Monoclonal antibodies (mAbs) Biosimilars Production Value and Growth Rate (2017-2028)

    • Figure Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Erythropoietin (EPO) (2017-2028)

    • Figure Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Human Growth Hormone (HGH) (2017-2028)

    • Figure Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Granulocyte- Colony Stimulating Factor (G-CSF) (2017-2028)

    • Figure Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Monoclonal Antibody (mAb) (2017-2028)

    • Figure Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Insulin (2017-2028)

    • Figure Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Interferon (IFN) (2017-2028)

    • Figure Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Celltrion (2017-2028)

    • Figure Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Anti-Cancer (2017-2028)

    • Figure Global Monoclonal antibodies (mAbs) Biosimilars Market Size and Growth Rate of Anti-Inflammatory/Autoimmune (2017-2028)

    • Figure North America Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Monoclonal antibodies (mAbs) Biosimilars Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Monoclonal antibodies (mAbs) Biosimilars Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Monoclonal antibodies (mAbs) Biosimilars Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Monoclonal antibodies (mAbs) Biosimilars Market Share, by Manufacturer in 2021

    • Figure Global and China Monoclonal antibodies (mAbs) Biosimilars Market Share, by Manufacturer in 2022

    • Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, by Type (2017-2028)

    • Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Type (2017-2028)

    • Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Type (2017-2028)

    • Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Value, by Type (2017-2028)

    • Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Value Share, by Type (2017-2028)

    • Figure Global Monoclonal antibodies (mAbs) Biosimilars Price Trend, by Type (2017-2028)

    • Table China Monoclonal antibodies (mAbs) Biosimilars Sales Volume, by Type (2017-2028)

    • Table China Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Type (2017-2028)

    • Figure China Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Type (2017-2028)

    • Table China Monoclonal antibodies (mAbs) Biosimilars Sales Value, by Type (2017-2028)

    • Table China Monoclonal antibodies (mAbs) Biosimilars Sales Value Share, by Type (2017-2028)

    • Figure China Monoclonal antibodies (mAbs) Biosimilars Price Trend, by Type (2017-2028)

    • Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, by Application (2017-2028)

    • Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Application (2017-2028)

    • Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Value, by Application (2017-2028)

    • Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Value Share, by Application (2017-2028)

    • Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Value Share, by Application (2017-2028)

    • Table China Monoclonal antibodies (mAbs) Biosimilars Sales Volume, by Application (2017-2028)

    • Table China Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure China Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Application (2017-2028)

    • Table China Monoclonal antibodies (mAbs) Biosimilars Sales Value, by Application (2017-2028)

    • Table China Monoclonal antibodies (mAbs) Biosimilars Sales Value Share, by Application (2017-2028)

    • Figure China Monoclonal antibodies (mAbs) Biosimilars Sales Value Share, by Application (2017-2028)

    • Figure China Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export (2017-2022)

    • Figure North America Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Production, Import, Consumption and Export (2017-2022)

    • Table North America Monoclonal antibodies (mAbs) Biosimilars Sales Volume, by Type (2017-2028)

    • Table North America Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Type (2017-2028)

    • Figure North America Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Type (2017-2028)

    • Table North America Monoclonal antibodies (mAbs) Biosimilars Sales Volume, by Application (2017-2028)

    • Table North America Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure North America Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure United States Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure United States Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Canada Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales Volume, by Type (2017-2028)

    • Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Type (2017-2028)

    • Figure Europe Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Type (2017-2028)

    • Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales Volume, by Application (2017-2028)

    • Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure Europe Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure Germany Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure UK Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure UK Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure France Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure France Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Italy Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Spain Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Poland Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Russia Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Table APAC Monoclonal antibodies (mAbs) Biosimilars Sales Volume, by Type (2017-2028)

    • Table APAC Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Type (2017-2028)

    • Figure APAC Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Type (2017-2028)

    • Table APAC Monoclonal antibodies (mAbs) Biosimilars Sales Volume, by Application (2017-2028)

    • Table APAC Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure APAC Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure China Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure China Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Japan Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure India Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure India Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Monoclonal antibodies (mAbs) Biosimilars Sales Value and Growth Rate (2017-2028)

    • Table 3SBio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table 3SBio Product Profiles, Application and Specification

    • Table 3SBio Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AET Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AET Biotech Product Profiles, Application and Specification

    • Table AET Biotech Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Dr Reddy's Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Dr Reddy's Laboratories Product Profiles, Application and Specification

    • Table Dr Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hospira Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hospira Product Profiles, Application and Specification

    • Table Hospira Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Allergan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Allergan Product Profiles, Application and Specification

    • Table Allergan Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amega Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amega Biotech Product Profiles, Application and Specification

    • Table Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Accord Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Accord Healthcare Product Profiles, Application and Specification

    • Table Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Others Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Others Product Profiles, Application and Specification

    • Table Others Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Biocon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biocon Product Profiles, Application and Specification

    • Table Biocon Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Celltrion Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Celltrion Product Profiles, Application and Specification

    • Table Celltrion Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US